Impact of ABO blood type on morbidity of organ dysfunction and mortality in septic patients: a single center retrospective observational study

Author:

ZHENG HongZhu1,JIN HuiYong1,ZHANG Qian2,SONG Haijing1,YI LingXian1

Affiliation:

1. Strategic Support Force Characteristic Medical Center of People’s Liberation Army

2. Chinese PLA General Hospital

Abstract

Abstract

Background Sepsis is a life-threatening organ dysfunction caused by dysregulated host immune response to infection. The relationship between ABO blood type and the occurrence of organ dysfunction the initial stages of sepsis and 28-day mortality has rarely been reported. This study aims to explore the potential association between ABO blood type and the incidence of organ dysfunction and 28-day mortality. This study was a single-center retrospective observational analysis, encompassing all septic patients admitted to our ICU from 2015 to 2021. Various patient characteristics were recorded. Results A total of 184 patients diagnosed with sepsis were enrolled in the study, with 166 meeting the specified inclusion criteria. The finding revealed a significant association between d/eOD and ABO blood type. Specifically, individuals with blood type B demonstrated the lowest incidence of d/eOD. Consequently, the septic patients were divided into two groups: blood type B and non-B blood types. Compared to non-B blood types, blood type B exhibited a lower incidence of d/eOD within 7-day (43.40% vs 26.67%, P = 0.03) and 28-day mortality (52.83% vs 26.67%, P < 0.00). Multivariate Cox regression analysis showed that both blood type B [HR 0.42, 95% CI (0.24–0.74), P < 0.01] and SOFA score [HR 1.14, 95% CI (1.05–1.24), P < 0.01] were associated with 28-day mortality. Additionally, blood type B was found to be an independent factor protecting against d/eOD [OR 0.48, 95% CI (0.24–0.96), P = 0.04]. Conclusion Blood type B has been found to a protective factor in the incidence of d/eOD during early-stage sepsis and 28-day mortality for septic patients.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3